These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 2809678)
21. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
22. Significance of a partial or slow response to front-line chemotherapy in the management of intermediate-grade or high-grade non-Hodgkin's lymphoma: a literature review. Haw R; Sawka CA; Franssen E; Berinstein NL J Clin Oncol; 1994 May; 12(5):1074-84. PubMed ID: 8164032 [TBL] [Abstract][Full Text] [Related]
23. Massive chemotherapy with autologous bone marrow transplantation in 50 cases of bad prognosis non-Hodgkin's lymphoma. Philip T; Biron P; Maraninchi D; Goldstone AH; Herve P; Souillet G; Gastaut JL; Plouvier E; Flesh Y; Philip I Br J Haematol; 1985 Aug; 60(4):599-609. PubMed ID: 3896295 [TBL] [Abstract][Full Text] [Related]
24. Accelerated hyperfractionated total-lymphoid irradiation, high-dose chemotherapy, and autologous bone marrow transplantation for refractory and relapsing patients with Hodgkin's disease. Yahalom J; Gulati SC; Toia M; Maslak P; McCarron EG; O'Brien JP; Portlock CS; Straus DJ; Phillips J; Fuks Z J Clin Oncol; 1993 Jun; 11(6):1062-70. PubMed ID: 8501492 [TBL] [Abstract][Full Text] [Related]
25. VACOP-B, high-dose cyclophosphamide and high-dose therapy with peripheral blood progenitor cell rescue for aggressive non-Hodgkin's lymphoma with bone marrow involvement: a study by the non-Hodgkin's Lymphoma Co-operative Study Group. Santini G; Coser P; Congiu AM; Salvagno L; De Souza C; Sertoli MR; Olivieri A; Chisesi T; Rubagotti A; Truini M; Contu A; Porcellini A; Zambaldi G; Nati S; Marino G; Rizzoli V Haematologica; 2000 Feb; 85(2):160-6. PubMed ID: 10681723 [TBL] [Abstract][Full Text] [Related]
26. The role of autologous bone marrow transplantation in 46 adult patients with non-Hodgkin's lymphomas. Colombat P; Gorin NC; Lemonnier MP; Binet C; Laporte JP; Douay L; Desbois I; Lopez M; Lamagnere JP; Najman A J Clin Oncol; 1990 Apr; 8(4):630-7. PubMed ID: 2313332 [TBL] [Abstract][Full Text] [Related]
27. High-dose therapy and autologous bone marrow transplantation in partial remission after first-line induction therapy for diffuse non-Hodgkin's lymphoma. Philip T; Hartmann O; Biron P; Cahn JY; Pein F; Bordigoni P; Souillet G; Gartner M; Lasset C; Chauvin F J Clin Oncol; 1988 Jul; 6(7):1118-24. PubMed ID: 3292712 [TBL] [Abstract][Full Text] [Related]
28. Practice guidelines for the management of extranodal non-Hodgkin's lymphomas of adult non-immunodeficient patients. Part I: primary lung and mediastinal lymphomas. A project of the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation. Zinzani PL; Martelli M; Poletti V; Vitolo U; Gobbi PG; Chisesi T; Barosi G; Ferreri AJ; Marchetti M; Pimpinelli N; Tura S; ; ; Haematologica; 2008 Sep; 93(9):1364-71. PubMed ID: 18603558 [TBL] [Abstract][Full Text] [Related]
29. Prolonged disease-free survival after autologous bone marrow transplantation in patients with non-Hodgkin's lymphoma with a poor prognosis. Takvorian T; Canellos GP; Ritz J; Freedman AS; Anderson KC; Mauch P; Tarbell N; Coral F; Daley H; Yeap B N Engl J Med; 1987 Jun; 316(24):1499-505. PubMed ID: 3295542 [TBL] [Abstract][Full Text] [Related]
30. Outcome of high-dose therapy and autologous transplantation in non-Hodgkin's lymphoma based on the presence of tumor in the marrow or infused hematopoietic harvest. Sharp JG; Kessinger A; Mann S; Crouse DA; Armitage JO; Bierman P; Weisenburger DD J Clin Oncol; 1996 Jan; 14(1):214-9. PubMed ID: 8558200 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease. Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A Bone Marrow Transplant; 1990 Feb; 5(2):99-103. PubMed ID: 2310878 [TBL] [Abstract][Full Text] [Related]
32. Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial. Stiff PJ; Dahlberg S; Forman SJ; McCall AR; Horning SJ; Nademanee AP; Blume KG; LeBlanc M; Fisher RI J Clin Oncol; 1998 Jan; 16(1):48-55. PubMed ID: 9440722 [TBL] [Abstract][Full Text] [Related]
33. [Therapeutic management of central nervous system lymphomas in a single hematological institute]. Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012 [TBL] [Abstract][Full Text] [Related]
34. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380 [TBL] [Abstract][Full Text] [Related]
35. High-dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European Bone Marrow Transplant Registry. Williams CD; Harrison CN; Lister TA; Norton AJ; Blystad AK; Coiffier B; Taghipour G; Schmitz N; Goldstone AH; J Clin Oncol; 2001 Feb; 19(3):727-35. PubMed ID: 11157024 [TBL] [Abstract][Full Text] [Related]
36. Autologous bone marrow transplantation for non-transformed low-grade non-Hodgkin's lymphoma. Cervantes F; Shu XO; McGlave PB; Ramsay NK; Miller WJ; Kersey JH; Weisdorf DJ Bone Marrow Transplant; 1995 Sep; 16(3):387-92. PubMed ID: 8535311 [TBL] [Abstract][Full Text] [Related]
37. High-dose chemotherapy with carboplatin, etoposide and ifosfamide followed by autologous stem cell rescue in patients with relapsed or refractory malignant lymphomas: a phase I/II study. Kleiner S; Kirsch A; Schwaner I; Kingreen D; Schwella N; Huhn D; Siegert W Bone Marrow Transplant; 1997 Dec; 20(11):953-9. PubMed ID: 9422474 [TBL] [Abstract][Full Text] [Related]
38. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study. Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334 [TBL] [Abstract][Full Text] [Related]
39. Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study. Snyder MJ; Johnson DB; Daly MB; Giguere JK; Harman GH; Harden EA; Johnson RA; Leff RS; Mercier RJ; Messerschmidt GL Bone Marrow Transplant; 1994 Oct; 14(4):595-600. PubMed ID: 7858534 [TBL] [Abstract][Full Text] [Related]
40. The treatment of relapsed or refractory intermediate grade non-Hodgkin's lymphoma with autologous bone marrow transplantation followed by cyclosporine and interferon. Gryn J; Johnson E; Goldman N; Devereux L; Grana G; Hageboutros A; Fernandez E; Constantinou C; Harrer W; Viner E; Goldberg J Bone Marrow Transplant; 1997 Feb; 19(3):221-6. PubMed ID: 9028549 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]